Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
© Yorkman - Shutterstock

Image courtesy of Shutterstock

A recently published study in the Emergency Medicine Journal reporting on the Initial Experience Setting up a Medical Student First Responder Scheme for life threatening emergencies in the community, a partnership developed and managed by the South Central Ambulance Service NHS Foundation Trust (SCAS) and Oxford University Medical School, confirms the schemes success.  The scheme, launched in 2013, recruits volunteers from fourth and fifth year medical students to provide early and often vital intervention for patients suffering life-threatening medical emergencies whilst an ambulance response is en route to the scene.

The study’s key findings include:

  • Confirmation of the feasibility of setting up a successful student first responder scheme developed and managed by the ambulance service in partnership with the medical school
  • Appropriate case selection, and good ambulance operational integration and support, has produced a really valuable training opportunity for medical students to initially assess unwell patients in the community in preparation for undertaking a similar role in hospital
  • A valuable opportunity to gain insight into the challenges of delivering care in the ambulance pre-hospital environment and an understanding of the role of the emergency services
  • A number of patients have benefited from timely access to basic life support and defibrillation following out of hospital cardiac arrest
  • Student feedback has confirmed that this experience was highly valued for not only for enhancing communication and clinical skills, but also for their leadership development

The scheme coordinators hope to extend the scheme to pre-clinical students, who will respond with a more experienced clinical medical student, giving them the opportunity to provide mentorship and support. They also hope to extend the scheme to include other allied healthcare professional students.

Paper: Initial experience in setting up a medical student first responder scheme in South Central England (Subscription may be required)

Related news: Oxford University medical students to be England's first Student Responders

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.